skip to main content


Title: Intermittent human-in-the-loop model selection using cerebro: a demonstration
Deep learning (DL) is revolutionizing many fields. However, there is a major bottleneck for the wide adoption of DL: the pain of model selection , which requires exploring a large config space of model architecture and training hyper-parameters before picking the best model. The two existing popular paradigms for exploring this config space pose a false dichotomy. AutoML-based model selection explores configs with high-throughput but uses human intuition minimally. Alternatively, interactive human-in-the-loop model selection completely relies on human intuition to explore the config space but often has very low throughput. To mitigate the above drawbacks, we propose a new paradigm for model selection that we call intermittent human-in-the-loop model selection . In this demonstration, we will showcase our approach using five real-world DL model selection workloads. A short video of our demonstration can be found here: https://youtu.be/K3THQy5McXc.  more » « less
Award ID(s):
1942724
NSF-PAR ID:
10337022
Author(s) / Creator(s):
; ;
Date Published:
Journal Name:
Proceedings of the VLDB Endowment
Volume:
14
Issue:
12
ISSN:
2150-8097
Page Range / eLocation ID:
2687 to 2690
Format(s):
Medium: X
Sponsoring Org:
National Science Foundation
More Like this
  1. Stereology-based methods provide the current state-of-the-art approaches for accurate quantification of numbers and other morphometric parameters of biological objects in stained tissue sections. The advent of artificial intelligence (AI)-based deep learning (DL) offers the possibility of improving throughput by automating the collection of stereology data. We have recently shown that DL can effectively achieve comparable accuracy to manual stereology but with higher repeatability, improved throughput, and less variation due to human factors by quantifying the total number of immunostained cells at their maximal profile of focus in extended depth of field (EDF) images. In the first of two novel contributions in this work, we propose a semi-automatic approach using a handcrafted Adaptive Segmentation Algorithm (ASA) to automatically generate ground truth on EDF images for training our deep learning (DL) models to automatically count cells using unbiased stereology methods. This update increases the amount of training data, thereby improving the accuracy and efficiency of automatic cell counting methods, without a requirement for extra expert time. The second contribution of this work is a Multi-channel Input and Multi-channel Output (MIMO) method using a U-Net deep learning architecture for automatic cell counting in a stack of z-axis images (also known as disector stacks). This DL-based digital automation of the ordinary optical fractionator ensures accurate counts through spatial separation of stained cells in the z-plane, thereby avoiding false negatives from overlapping cells in EDF images without the shortcomings of 3D and recurrent DL models. The contribution overcomes the issue of under-counting errors with EDF images due to overlapping cells in the z-plane (masking). We demonstrate the practical applications of these advances with automatic disector-based estimates of the total number of NeuN-immunostained neurons in a mouse neocortex. In summary, this work provides the first demonstration of automatic estimation of a total cell number in tissue sections using a combination of deep learning and the disector-based optical fractionator method. 
    more » « less
  2. Atomic force microscopy (AFM) provides a platform for high-resolution topographical imaging and the mechanical characterization of a wide range of samples, including live cells, proteins, and other biomolecules. AFM is also instrumental for measuring interaction forces and binding kinetics for protein–protein or receptor–ligand interactions on live cells at a single-molecule level. However, performing force measurements and high-resolution imaging with AFM and data analytics are time-consuming and require special skill sets and continuous human supervision. Recently, researchers have explored the applications of artificial intelligence (AI) and deep learning (DL) in the bioimaging field. However, the applications of AI to AFM operations for live-cell characterization are little-known. In this work, we implemented a DL framework to perform automatic sample selection based on the cell shape for AFM probe navigation during AFM biomechanical mapping. We also established a closed-loop scanner trajectory control for measuring multiple cell samples at high speed for automated navigation. With this, we achieved a 60× speed-up in AFM navigation and reduced the time involved in searching for the particular cell shape in a large sample. Our innovation directly applies to many bio-AFM applications with AI-guided intelligent automation through image data analysis together with smart navigation. 
    more » « less
  3. Abstract Autonomous process optimization involves the human intervention-free exploration of a range process parameters to improve responses such as product yield and selectivity. Utilizing off-the-shelf components, we develop a closed-loop system for carrying out parallel autonomous process optimization experiments in batch. Upon implementation of our system in the optimization of a stereoselective Suzuki-Miyaura coupling, we find that the definition of a set of meaningful, broad, and unbiased process parameters is the most critical aspect of successful optimization. Importantly, we discern that phosphine ligand, a categorical parameter, is vital to determination of the reaction outcome. To date, categorical parameter selection has relied on chemical intuition, potentially introducing bias into the experimental design. In seeking a systematic method for selecting a diverse set of phosphine ligands, we develop a strategy that leverages computed molecular feature clustering. The resulting optimization uncovers conditions to selectively access the desired product isomer in high yield. 
    more » « less
  4. Skolnick, Jeffrey (Ed.)
    Systematically discovering protein-ligand interactions across the entire human and pathogen genomes is critical in chemical genomics, protein function prediction, drug discovery, and many other areas. However, more than 90% of gene families remain “dark”—i.e., their small-molecule ligands are undiscovered due to experimental limitations or human/historical biases. Existing computational approaches typically fail when the dark protein differs from those with known ligands. To address this challenge, we have developed a deep learning framework, called PortalCG, which consists of four novel components: (i) a 3-dimensional ligand binding site enhanced sequence pre-training strategy to encode the evolutionary links between ligand-binding sites across gene families; (ii) an end-to-end pretraining-fine-tuning strategy to reduce the impact of inaccuracy of predicted structures on function predictions by recognizing the sequence-structure-function paradigm; (iii) a new out-of-cluster meta-learning algorithm that extracts and accumulates information learned from predicting ligands of distinct gene families (meta-data) and applies the meta-data to a dark gene family; and (iv) a stress model selection step, using different gene families in the test data from those in the training and development data sets to facilitate model deployment in a real-world scenario. In extensive and rigorous benchmark experiments, PortalCG considerably outperformed state-of-the-art techniques of machine learning and protein-ligand docking when applied to dark gene families, and demonstrated its generalization power for target identifications and compound screenings under out-of-distribution (OOD) scenarios. Furthermore, in an external validation for the multi-target compound screening, the performance of PortalCG surpassed the rational design from medicinal chemists. Our results also suggest that a differentiable sequence-structure-function deep learning framework, where protein structural information serves as an intermediate layer, could be superior to conventional methodology where predicted protein structures were used for the compound screening. We applied PortalCG to two case studies to exemplify its potential in drug discovery: designing selective dual-antagonists of dopamine receptors for the treatment of opioid use disorder (OUD), and illuminating the understudied human genome for target diseases that do not yet have effective and safe therapeutics. Our results suggested that PortalCG is a viable solution to the OOD problem in exploring understudied regions of protein functional space. 
    more » « less
  5. Deep learning (DL) is growing in popularity for many data analytics applications, including among enterprises. Large business-critical datasets in such settings typically reside in RDBMSs or other data systems. The DB community has long aimed to bring machine learning (ML) to DBMS-resident data. Given past lessons from in-DBMS ML and recent advances in scalable DL systems, DBMS and cloud vendors are increasingly interested in adding more DL support for DB-resident data. Recently, a new parallel DL model selection execution approach called Model Hopper Parallelism (MOP) was proposed. In this paper, we characterize the particular suitability of MOP for DL on data systems, but to bring MOP-based DL to DB-resident data, we show that there is no single "best" approach, and an interesting tradeoff space of approaches exists. We explain four canonical approaches and build prototypes upon Greenplum Database, compare them analytically on multiple criteria (e.g., runtime efficiency and ease of governance) and compare them empirically with large-scale DL workloads. Our experiments and analyses show that it is non-trivial to meet all practical desiderata well and there is a Pareto frontier; for instance, some approaches are 3x-6x faster but fare worse on governance and portability. Our results and insights can help DBMS and cloud vendors design better DL support for DB users. All of our source code, data, and other artifacts are available at https://github.com/makemebitter/cerebro-ds. 
    more » « less